two chamber cpp apparatus (Med Associates Inc)
95
Structured Review
Med Associates Inc
two chamber cpp apparatus
Two Chamber Cpp Apparatus, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 95/100, based on 276 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chamber+cpp+apparatus/CPP+Chamber/pm41565998-101-14-17
Average 95 stars, based on 276 article reviews
Two Chamber Cpp Apparatus, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 95/100, based on 276 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chamber+cpp+apparatus/CPP+Chamber/pm41565998-101-14-17
Average 95 stars, based on 276 article reviews
two chamber cpp apparatus - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
other:Article Title: The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: relationship to sex-differences. Article Snippet: Apparatus: Morphine conditioning occurred in a Article Title: Selective block of sensory neuronal T-type/Cav3.2 activity mitigates neuropathic pain behavior in a rat model of osteoarthritis pain. Article Snippet: A Article Title: Identification of small molecule ligands for GPR83 that modulate morphine antinociception and reward. Article Snippet: The opioid crisis showcases a need for novel therapeutic avenues to treat drug abuse.. GPR83, a recently deorphanized G protein-coupled receptor shown to blunt morphine reward learning and regulate pain, is activated by the neuropeptide PEN and peptides derived from cholecystokinin.. To identify small molecule ligands, we generated a homology model based on the crystal structure of related receptors and used virtual screening on a library of 7 million compounds. Article Title: Efficacy of GABA aminotransferase inactivator OV329 in models of neuropathic and inflammatory pain without tolerance or addiction. Article Snippet: Dysregulation of GABAergic transmission is linked to pathological pain.. Inhibition of the enzyme GABA aminotransferase (GABA-AT) represents a potential therapeutic strategy to normalize aberrant excitability and suppress neuropathic and inflammatory pain.. The GABA-AT inhibitor OV329 suppressed pathological pain without producing tolerance or apparent addiction liability, raising the possibility that a beneficial spectrum of therapeutic effects in pain management may be achieved through enzyme regulation. Article Title: Selective block of sensory neuronal T-type/Cav3.2 activity mitigates neuropathic pain behavior in a rat model of osteoarthritis pain Article Snippet: A Article Title: Targeting intrinsically disordered regions facilitates discovery of calcium channels 3.2 inhibitory peptides for adeno-associated virus-mediated peripheral analgesia. Article Snippet: A Article Title: Peripherally targeted analgesia via AAV-mediated sensory neuron–specific inhibition of multiple pronociceptive sodium channels Article Snippet: A Article Title: Selective block of sensory neuronal T-type/Cav3.2 activity mitigates neuropathic pain behavior in a rat model of osteoarthritis pain Article Snippet: A |